Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
Promising treatments for neurogenerative disorders may involve targeting kinetic intermediates, including α-synuclein oligomers. Here a kinetic method for quantifying oligomer populations is used to screen small molecule inhibitors of oligomerisation and gain mechanistic insight into their modes of...
Guardado en:
Autores principales: | Roxine Staats, Thomas C. T. Michaels, Patrick Flagmeier, Sean Chia, Robert I. Horne, Johnny Habchi, Sara Linse, Tuomas P. J. Knowles, Christopher M. Dobson, Michele Vendruscolo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25cc20ef6fa54796a866e8e34065ca87 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers
por: Francesco Simone Ruggeri, et al.
Publicado: (2021) -
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Rodrigo Cataldi, et al.
Publicado: (2021) -
Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes
por: Ryan Limbocker, et al.
Publicado: (2019) -
Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Rodrigo Cataldi, et al.
Publicado: (2021) -
Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity
por: Francesco Simone Ruggeri, et al.
Publicado: (2018)